LEIPZIG, Germany and ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Switzerland’s ESPAS, a ...
AstraZeneca and Merck & Co have cemented their lead in the PARP inhibitor class with FDA approval for Lynparza in pancreatic cancer, extending the drug’s use into a third type of solid tumour. The US ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results